Morgan Stanley lowered the firm’s price target on Nucor (NUE) to $166 from $170 and keeps an Overweight rating on the shares. The firm is updating estimates following Q3 earnings to include the company Q4 guidance and commentary.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUE:
- Closing Bell Movers: Medpace down 11% after cutting FY24 revenue guide
- NUE Earnings: Nucor Slides after Q3 EPS Misses Estimates
- Nucor’s Q3 Earnings Drop but Strategic Growth Persists
- Nucor reports Q3 adjusted EPS $1.49, consensus $1.47
- Nucor expects earnings in Q4 to decrease compared to Q3 EPS of $1.05